NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 212 filers reported holding NOVAVAX INC in Q2 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,343,627 | +103.3% | 461,827 | +108.7% | 0.01% | +125.0% |
| Q2 2023 | $1,644,356 | +197.8% | 221,313 | +177.8% | 0.00% | +300.0% |
| Q1 2023 | $552,134 | +176.2% | 79,673 | +309.7% | 0.00% | 0.0% |
| Q4 2022 | $199,936 | +156.3% | 19,449 | +355.9% | 0.00% | – |
| Q3 2022 | $78,000 | -73.5% | 4,266 | -25.3% | 0.00% | -100.0% |
| Q2 2022 | $294,000 | -87.7% | 5,712 | -82.4% | 0.00% | -80.0% |
| Q1 2022 | $2,385,000 | +279.8% | 32,389 | +835.8% | 0.01% | +400.0% |
| Q1 2021 | $628,000 | -75.4% | 3,461 | -85.3% | 0.00% | -83.3% |
| Q3 2020 | $2,548,000 | -60.0% | 23,519 | -69.2% | 0.01% | -62.5% |
| Q2 2020 | $6,366,000 | +1545.0% | 76,379 | +167.8% | 0.02% | +1500.0% |
| Q1 2020 | $387,000 | +74.3% | 28,520 | -48.9% | 0.00% | – |
| Q4 2019 | $222,000 | +181.0% | 55,836 | +253.8% | 0.00% | – |
| Q3 2019 | $79,000 | -7.1% | 15,784 | +8.6% | 0.00% | – |
| Q2 2019 | $85,000 | – | 14,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |